期刊文献+

p38MAPK对慢性前列腺炎疼痛的影响及槲皮素的干预作用 被引量:25

Effects of p38MAPK on Rats with Chronic Nonbacterial Prostatitis Neuralgia and the Intervention Effect of Quercetin
原文传递
导出
摘要 目的探讨槲皮素对前列腺炎疼痛抑制作用的可能机制。方法利用同源大鼠前列腺蛋白提取液辅以弗氏完全佐剂诱导大鼠自身免疫性前列腺炎模型,槲皮素灌胃给药10周后,用HE染色法观察各组大鼠前列腺组织形态学差异;ELISA法测定各组血清中IL-8、TNF-α及内皮中性粒细胞激活肽78(endothelial neutrophil activating protein,ENA-78)的含量变化;免疫组化法测定神经生长因子(nerve growth factor,NGF)在前列腺组织内的表达;Western blotting法测定前列腺组织内基质金属蛋白酶9(matrix metalloproteinase-9,MMP-9)、磷酸化p38丝裂原活化蛋白激酶(p-p38MAPK)及总p38丝裂原活化蛋白激酶(p38MAPK)表达的变化。结果与模型对照组比较,槲皮素能不同程度减轻各组前列腺组织的炎症状况;模型对照组血清IL-8、TNF-α及ENA-78含量明显增高,槲皮素200 mg·kg?1能明显降低慢性前列腺炎大鼠血清IL-8、TNF-α及ENA-78的水平(P<0.05);200,100,50 mg·kg?1槲皮素给药均能不同程度抑制NGF在前列腺组织的原位表达;槲皮素200 mg·kg?1组与模型对照组比较,MMP-9、总p38MAPK及p-p38MAPK表达量不同程度降低。结论在大鼠慢性前列腺炎模型,p38MAPK信号转导途径被激活,槲皮素可同步降低细胞因子IL-8、TNF-α、ENA-78的含量及p38MAPK、p-p38MAPK的表达,这为槲皮素治疗前列腺炎疼痛提供一条新思路。 OBJECTIVE To explore the possible mechanism of quercetin on neuralgia in chronic nonbacterial prostatitis(CNP) rats. METHODS The CNP rat models were established by prostatic protein purification with Freund's completed adjuvant. The morphological differences in the prostate tissue were observed by HE staining. The changes of the content of IL-8, TNF-α and ENA-78 in serum were evaluated by ELISA. The expression of NGF were evaluated by immunohistochemistry. The expression of MMP-9, p-p38 MAPK and p38 MAPK were evaluated by Western blotting. RESULTS The pathological alterations of chronic prostatitis in quercetin groups were improved compared with model group; the content of IL-8, TNF-α and ENA-78 in model group were increased, but 200 mg·kg^-1 dose group of quercetin could obviously reduce the serumal content of IL-8, TNF-α and ENA-78; 200 mg·kg^-1 dose group of quercetin could obviously reduce prostate expression of NGF, p-p38 MAPK and p38 MAPK. CONCLUSION P38 MAPK signal pathway is activated in CNP rats. Quercetin can drcrease the content of IL-8, TNF-α and ENA-78, and down-regulate the expression of p38 MAPK and p-p38 MAPK, which may provide a new way for the treatment of nonbacterial prostatitis neuralgia.
出处 《中国现代应用药学》 CAS CSCD 2016年第8期984-988,共5页 Chinese Journal of Modern Applied Pharmacy
基金 浙江省科技计划项目(2013C33196) 浙江省中医药科技计划项目(2012ZB021)
关键词 前列腺炎 疼痛 槲皮素 P38MAPK prostatitis neuralgia quercetin p38MAPK
  • 相关文献

参考文献16

  • 1MOTRICH R D, MACCIONI M, R1ERA C M, et al.Antoimmune prostatitis: state of the art [J].Scand J Immunol,2007,66(2/3):217-227.
  • 2KRIEGER J N, RILEY D E, CHE AH P Y, et al.Epidemiology of prostatitis: new evidence for a world-wideproblem [J].World J Urol, 2003, 21(2): 70-74.
  • 3L1TWIN M S. A review of the development and validation ofthe National Institutes of Health Chronic Prostatitis SymptomIndex [J].Urology,2002, 60(6 SuppI): 14-18.
  • 4程丽艳,郑晓亮,史红.槲皮素对非细菌性前列腺炎治疗作用的实验研究[J].中国临床药理学与治疗学,2008,13(6):648-653. 被引量:16
  • 5张良,程丽艳,史红.槲皮素对自身免疫性前列腺炎模型COX-2及5-LOX表达的影响[J].中华中医药学刊,2014,32(3):600-602. 被引量:5
  • 6RIVERO V E, MOTRICH R D, MACCIONI M, et al.Autoimmune etiology in chronic prostatitis syndrome: anadvance in the understanding of this pathology [J], Crit RevImmunol, 2007, 27(1): 33-46.
  • 7SHOSKES D A, NICKEL J C. Quercetin for chronicprostatitis/chronic pelvic pain syndrome [J].Urol Clin NorthAm, 2011,38(3): 279-284.
  • 8HOCHREITER W W, NADLER R B,KOCH A E, et al.Evaluation of the cytokines interleukin 8 and epithelialneutrophil activating peptide 78 as indicators of inflammationin prostatic secretions [J].Urology , 2000,56(6): 1025-1029 .
  • 9KHADRA A, FLETCHER P, LUZZI G, et al Interleukin-8levels in seminal plasma in chronic prostatitis/chronic pelvicpain syndrome and nonspecific urethritis [J].BJU Int, 2006,97(5): 1043- 1046.
  • 10NADLER R B, KOCH A E, CALHOUN E A, et al. IL-l(3 andTNF-a in prostatic secretions are indicators in the evaluationof men with chronic prostatitis [J].J Urol, 2000, 164(1):214-218.

二级参考文献30

  • 1魏武然,张唯力,戴君勇.大鼠慢性非细菌性前列腺炎模型的建立[J].中国男科学杂志,2006,20(1):22-24. 被引量:67
  • 2Shoskes DA, Zeitlin SI, Shahed A, et al. Quercetin in men with category Ⅲ chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial [ J]. Urology, 1999,54(6) :960 - 963.
  • 3Luzzi GA. Chronic prostatitis and chronic pelvic pain in men: aetiology, diagnosis and management [ J]. J Eur Acad Dermatol Venereol, 2002, 16(3) :253 - 256.
  • 4Shoskes DA. Use of the bioflavonoid quercetin in patients with longstanding chronic prostatitis[J]. J Am Neutraceut Assoe, 1999,2:18 - 21.
  • 5Wibo M, Godfraind T. Comparative localization of inositol 1,4,5-trisphosphate and ryanodine receptors in intestinal smooth muscle: an analytical subfractionation study [ J]. Biochem J, 1994,297(2) :415 - 423.
  • 6Medical Economics, ed. Physician's Desk Reference (PDR) for HerbalMedicines[M]. Montvale, NJ: Thomson Heahhcare, 1998: 22 - 25.
  • 7Lee JC, Muller CH, Ivan R, et al. Prostate biopsy culture findings of men with CPPS do not differ from those of healthy controls[J]. J Urol,2003,169(2) :584 - 588.
  • 8Tanner MA, Shoskes D, Shahed A, et al. Prevalence of corynebacterial 16S rRNA sequences in patients with bacterial and non-bacterial prostatitis[J]. J Clin Microbiol, 1999,37(6) : 1863 - 1869.
  • 9John H, Barghom A, Funke G, et al. Noninflammatory chronic pelvic pain syndrome: immunological study inblood,ejuculate and prostate tissue[ J]. Eur Urol, 2001, 39( 1 ) :72.
  • 10Shahed A, Shoskes DA. Oxidative stress in prostatic fluid of patients with chronicpelvic pain syndrome: correlation with gram positivebacterial growth and treatment response [J]. J Androl, 2000,21(5) :669 - 675.

共引文献22

同被引文献441

引证文献25

二级引证文献223

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部